Low-dose preparative regimen and allogeneic stem cell transplantation in patients with multiple myeloma relapsing after autografting.

被引：0
|
作者：
Einsele, H
Bamberg, M
Schäfer, HJ
Hebart, H
Bader, P
Budach, W
Faul, C
Brugger, W
Kanz, L
机构：
[1] Dept Hematol & Oncol, Tubingen, Germany
[2] Dept Pediat, Tubingen, Germany
[3] Dept Radiotherapy, Tubingen, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4607
引用
下载
收藏
页码：309B / 309B
页数：1
相关论文
共 50 条
  • [1] Allogeneic Stem Cell Transplantation As Salvage Therapy for First Relapse after Autografting in Multiple Myeloma Patients
    Klyuchnikov, Evgeny
    Wolschke, Christine
    Badbaran, Anita
    Christopeit, Maximilian
    von Pein, Ute-Marie
    Ayuk, Francis A.
    Kroger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [2] Low-dose grafts in multiple myeloma after autologous stem cell transplantation
    Sauer, S.
    Pavel, P.
    Schmitt, A.
    Cremer, M.
    Kriegsmann, M.
    Bruckner, T.
    Jordan, K.
    Wuchter, P.
    Mueller-Tidow, C.
    Kriegsmann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 124 - 124
  • [3] Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Renges, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, AR
    BLOOD, 2004, 104 (10) : 3361 - 3363
  • [4] Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Renges, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S47 - S47
  • [5] Haplo-Identical Stem Cell Transplantation for Patients with Multiple Myeloma Who Relapsed after Autografting. a Study from the Cmwp of EBMT
    Kroeger, Nicolaus
    Eikema, Diderik-Jan
    Knelange, Nina Simone
    Koc, Yener
    Moraleda, Jose M.
    Dreger, Peter
    Schouten, Harry C.
    Kanz, Lothar
    Tischer, Johanna
    Corradini, Paolo
    Veelken, Hendrik
    Schaap, Michel
    Zuckerman, Tsila
    Volin, Liisa
    Russell, Nigel H.
    Jindra, Pavel
    Beguin, Yves
    Ehninger, Gerhard
    Ciceri, Fabio
    Blaise, Didier
    Diez-Martin, Jose L.
    Petersen, Eefke
    Schonland, Stefan
    Garderet, Laurent
    BLOOD, 2017, 130
  • [6] An intensified preparative regimen followed by allogeneic hematopoietic cell transplantation in patients with multiple myeloma (MM).
    Magalhaes-Silverman, M
    Oliveira, M
    Lee, CK
    Hohl, R
    Gingrich, R
    Ritchie, J
    BLOOD, 2001, 98 (11) : 196A - 196A
  • [7] Thalidomide as a preparative regimen and late stem cell transplantation in patients with relapsed or refractory multiple myeloma
    Hus, M
    Dmoszynska, A
    Legiec, W
    Jawniak, D
    Soroka-Wojtaszko, M
    Manko, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S251 - S252
  • [8] Fludarabine and low dose of melphalan as effective conditioning regimen for allogeneic stem cell transplantation in lymphoproliferative diseases and multiple myeloma
    Yanez, L.
    Bermudez, A.
    Perez, G.
    Diez, Z.
    Richard, C.
    Iriondo, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S404 - S405
  • [9] Bortezomib as salvage therapy for patients with multiple myeloma relapsing after a reduced intensity allogeneic stem cell transplantation
    Garcia Guinon, A.
    Sureda, A.
    Beltran, J.
    Bravo, S. J.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S158 - S158
  • [10] Allografting with immunosuppressive conditioning of low-dose fludarabine-cyclophosphamide after autografting.
    Carella, AM
    Cavaliere, M
    Corsetti, MT
    Lerma, E
    BLOOD, 2000, 96 (11) : 553A - +
12345